Skip to content

Drug interactions

Tamoxifen + Zafirlukast

Severity: Minor

Tamoxifen and Zafirlukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tamoxifen is activated to endoxifen mainly by CYP2D6, with CYP3A4 and CYP2C9 contributing to other pathways. The legacy rationale of reduced activation through CYP2C9 inhibition is weak, and the clinical effect on efficacy is unproven.

What this interaction means in plain words

Tamoxifen and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Tamoxifen belongs to Endocrine; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Possible minor inhibition of CYP2C9 and CYP3A4 pathways of tamoxifen metabolism by zafirlukast; clinical significance is not established.

What to do

No dose change is required. Be aware of the theoretical effect and avoid adding strong CYP2D6 inhibitors.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Tamoxifen and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Tamoxifen with Zafirlukast?

MediHelp rates the interaction as minor. Tamoxifen and Zafirlukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tamoxifen is activated to endoxifen mainly by CYP2D6, with CYP3A4 and CYP2C9 contributing to other pathways. The legacy rationale of reduced activation through CYP2C9 inhibition is weak, and the clinical effect on efficacy is unproven.

How serious is the interaction between Tamoxifen and Zafirlukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is required. Be aware of the theoretical effect and avoid adding strong CYP2D6 inhibitors.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in